Condition: Ventricular Tachycardia (VT) · Sponsor: Universitaire Ziekenhuizen KU Leuven
Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.
This description comes directly from the study's public registry record.
Bert Vandenberk, MD PhD · +3216338686 · bert.vandenberk@uzleuven.be
Patrick Berkovic, MD PhD · patrick.berkovic@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06744530